1
Views
1
CrossRef citations to date
0
Altmetric
Case Reports

Light Chain Nephropathy

, , &
Pages 207-209 | Received 18 Dec 1990, Accepted 10 May 1991, Published online: 31 Mar 2016

References

  • Cantaluppi A. 1988 CAPD and systemic diseases. Clin Nephrol 30: Suppl 1:8–11.
  • Cavo M, Galieni P, Gobbi M, Baldrati L, Leordini L, Baccarani M, Tura. S. Non-secretory myeloma: presenting findings, clinical course and prognosis. Acta Haematol 1985; 74: 27–30.
  • Clune DH, Pesce AJ, Thompson RE. Nephrotoxicity of Bence-Jones proteins in the rat. Importance of protein isoelectric point. Kidney Int 1979; 16: 345–352.
  • Confalonieri R, Barbiono di Belgiojoso, Banfi G, Ferrario F, Bertani T, Pozzic Casanova S, Lupo A, De Ferrari G, Minetti L. Light chain nephropathy: Histological and Clinical aspects in 15 cases. Nephrol Dial Transplant 1988; 2: 150–156.
  • Coward RA, Delamore IW, Mallick NP, Robinson EL. The importance of urinary immunoglobulin light chain isoelectric point (pi) in nephrotoxicity in multiple myeloma. Clin ScH984; 66: 229–232.
  • Fang LST. Light chain nephropathy. Kidney Int 1985; 26: 1–9.
  • Galo GR, Feiner HD, Katz LA, Feldman GM, Correa EB, Chuba JV, Buxbaum JN. Nodular Glomerulopathy associated with non amyloidotic Kappa chain deposits and excess immunoglobulin light chain synthesis. Am J Pathol 1980; 99: 621–632.
  • Ganeval D, Noel LH, Psued’homme JL, Droz D, Grunfeld JP. Light chain deposition disease in relation with AL-typc amyloidosis. Kidney Int 1984; 26: 1–9.
  • Johnson WJ, Kyle RA, Dahlberg PJ. Dialysis in the treatment of multiple myeloma. Mayo Clin Proc 1980; 16: 345–352.
  • Kyle RA. Multiple myeloma. Review of 869 cases. Mayo Clin Proc 1975; 50: 29–40.
  • Pardo V, Strauss J, Kramer H. Ozawa T. McIn-tosh RM. Nephropathy associated with sickle cell anaemia: an analogous immune complex nephritis II. Clinicopathologic study of seven patients. Am J Med 1975; 59: 650–659.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.